BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25787045)

  • 1. Modulation of the QT interval duration in hypertension with antihypertensive treatment.
    Klimas J; Kruzliak P; Rabkin SW
    Hypertens Res; 2015 Jul; 38(7):447-54. PubMed ID: 25787045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dispersion of the QT interval and autonomic modulation of heart rate in hypertensive men with and without left ventricular hypertrophy.
    Perkiömäki JS; Ikäheimo MJ; Pikkujämsä SM; Rantala A; Lilja M; Kesäniemi YA; Huikuri HV
    Hypertension; 1996 Jul; 28(1):16-21. PubMed ID: 8675257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study.
    Oikarinen L; Nieminen MS; Viitasalo M; Toivonen L; Jern S; Dahlöf B; Devereux RB; Okin PM;
    Hypertension; 2004 May; 43(5):1029-34. PubMed ID: 15037560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of telmisartan on QT interval variability and autonomic control in hypertensive patients with left ventricular hypertrophy.
    Galetta F; Franzoni F; Fallahi P; Tocchini L; Graci F; Carpi A; Antonelli A; Santoro G
    Biomed Pharmacother; 2010 Oct; 64(8):516-20. PubMed ID: 20044234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study.
    Oikarinen L; Nieminen MS; Toivonen L; Viitasalo M; Wachtell K; Papademetriou V; Jern S; Dahlöf B; Devereux RB; Okin PM;
    Am Heart J; 2003 May; 145(5):919-25. PubMed ID: 12766755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent ventricular repolarization markers in resistant hypertension: are they different from the traditional QT interval?
    Salles GF; Cardoso CR; Leocadio SM; Muxfeldt ES
    Am J Hypertens; 2008 Jan; 21(1):47-53. PubMed ID: 18091743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
    Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
    Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular hypertrophy and QT dispersion in hypertension.
    Mayet J; Shahi M; McGrath K; Poulter NR; Sever PS; Foale RA; Thom SA
    Hypertension; 1996 Nov; 28(5):791-6. PubMed ID: 8901825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QT-interval variability and autonomic control in hypertensive subjects with left ventricular hypertrophy.
    Piccirillo G; Germanò G; Quaglione R; Nocco M; Lintas F; Lionetti M; Moisè A; Ragazzo M; Marigliano V; Cacciafesta M
    Clin Sci (Lond); 2002 Mar; 102(3):363-71. PubMed ID: 11869178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined QT interval and voltage criteria improve left ventricular hypertrophy detection in resistant hypertension.
    Salles G; Leocádio S; Bloch K; Nogueira AR; Muxfeldt E
    Hypertension; 2005 Nov; 46(5):1207-12. PubMed ID: 16203872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nebivolol on QT dispersion in hypertensive patients with left ventricular hypertrophy.
    Galetta F; Franzoni F; Magagna A; Femia FR; Pentimone F; Santoro G; Carpi A
    Biomed Pharmacother; 2005; 59(1-2):15-9. PubMed ID: 15740930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converting enzyme inhibition normalizes QT interval in spontaneously hypertensive rats.
    Baillard C; Mansier P; Ennezat PV; Mangin L; Medigue C; Swynghedauw B; Chevalier B
    Hypertension; 2000 Sep; 36(3):350-4. PubMed ID: 10988263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepant regulation of QT (QTc) interval duration by calcium channel blockade and angiotensin converting enzyme inhibition in experimental hypertension.
    Klimas J; Vaja V; Vercinska M; Kyselovic J; Krenek P
    Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):279-88. PubMed ID: 22626243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regression of left ventricular hypertrophy with antihypertensive therapy].
    Follath F
    Ther Umsch; 1998 Sep; 55(9):539-41. PubMed ID: 9789465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
    Wachtell K; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Nieminen MS; Olsen MH; Okin PM; Palmieri V; Rokkedal JE; Devereux RB
    Blood Press; 2010 Jun; 19(3):169-75. PubMed ID: 20438307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of ventricular repolarization in an experimental model of arterial hypertension associated with obesity].
    Pathak A; Verwaerde P; Galinier M; Pelat M; Couderc PP; Rouet P; Smih F; Buys S; Montastruc JL; Senard JM
    Arch Mal Coeur Vaiss; 2002; 95(7-8):651-5. PubMed ID: 12365074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of QT-interval parameters for cardiovascular risk stratification in type 2 diabetic patients with arterial hypertension.
    Salles GF; Deccache W; Cardoso CR
    J Hum Hypertens; 2005 Mar; 19(3):241-9. PubMed ID: 15660120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of candesartan versus amlodipine on home-measured blood pressure, QT dispersion and left ventricular hypertrophy in high-risk hypertensive patients.
    Matsuno Y; Minatoguchi S; Fujiwara H;
    Blood Press Suppl; 2011 Apr; 1():12-9. PubMed ID: 21247247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT dispersion in essential hypertension.
    Clarkson PB; Naas AA; McMahon A; MacLeod C; Struthers AD; MacDonald TM
    QJM; 1995 May; 88(5):327-32. PubMed ID: 7796087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
    JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.